Martin Körbling - Concepedia

Author

Martin Körbling

The University of Texas MD Anderson Cancer Center

Also Known As

Ana Aleman, M Korbling, M Körbling, MARTIN KORBLING, MARTIN KÖRBLING, Martin J. Korbling, Martin Korbling, Martin Körbling, Martin Körbling

160

Publications

9.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Heidelberg University Lymphoma Research Foundation Cellular Therapeutics (United Kingdom)Baylor College of Medicine

About

Martin Körbling is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.1K
2	Health Sciences	8	8	302
3	Blood Transplantation	5	5	399
4	Biomedical Engineering	3	3	95
5	Public Health	1	1	28

Martin Körbling

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy Sergio Giralt, Elihu H. Estey, Maher Albitar, Blood	1997	1.2K
Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells Martin Körbling, Ruth L. Katz, Abha Khanna, New England Journal of Medicine	2002	768
Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture Marcos de Lima, Ian McNiece, Simon N. Robinson, New England Journal of Medicine	2012	472
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS Marcos de Lima, Daniel R. Couriel, Peter F. Thall, Blood	2004	421
Transdifferentiation of Human Peripheral Blood CD34 <sup>+</sup> -Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo Edward T.H. Yeh, Sui Zhang, Henry Wu, Circulation	2003	420
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality Issa F. Khouri, Rima M. Saliba, Sergio Giralt, Blood	2001	363
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Blood	2008	293
High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation Stefan O. Ciurea, Marcos de Lima, Pedro Cano, Transplantation HlaHistocompatibilityImmunologyTransplantation MedicinePathology	2009	281
Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation Stefan O. Ciurea, Victor E. Mulanovich, Rima M. Saliba, Biology of Blood and Marrow Transplantation	2012	245
Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation Donna Przepiorka, Terry L. Smith, Jody Folloder, Blood	1999	223

Page 1